If You Read Arabic
You might be interested in some coverage my research team got in Qatar, for our study on oncology decision making. (Link) Maybe one of you can translate it for me?

I just came across an interesting article in Slate contending that we often perceive handsome men to be jerks because examples of jerky handsome men come more easily to mind than examples of jerky plain men. In the case of single women, the “acceptable” men that they consider entering into relationships with tend to be better…
I remember one time having a conversation with Daniel Kahneman, one of the founders of behavioral economics, about the topic of happiness and emotional adaptation, in the context of chronic disability. We were discussing emotional impact of experiencing a limb amputation. Kahneman pointed out that it is the loss of the limb that is really…
In case the Internet had any remaining credibility, as a source of truthful information, the MBA channel now lists me as a B School legend: The U.S. based website Poets & Quants has published a different kind of ranking. They haven’t chosen the best b-schools, but instead paid tribute to some of the best b-school…
In the last few decades, medical schools have been teaching us doctors to inform patients about their treatment alternatives, so our patients can pick the alternative that best fits with their individual values. Which raises the question: Should doctors take the time to figure out the cost of treatment alternatives and communicate such information to their patients? Read More
In another great New Yorker article, Lauren Collins writes about controversy over taxing wealthy people in France, a controversy that has already caused Gerard Depardieu to move to Belgium and/or Russia. At one point in the article, she interviews experts to get their views on whether such taxes are effective in raising revenue. One expert…
Matthew Herper and Erin Carlyle at Forbes magazine recently put together a wonderful picture, showing what kinds of diseases pharmaceutical companies are targeting now in developing new drugs. The bigger the bubble, the larger the number of drugs under development. Further to the right, the deadlier the disease. Makes for fascinating picture: Several things strike…